Posts

ulrich medical USA™ New Hire Announcements

November 2022

New Hire Announcements


Alix Furgang

We are pleased to announce Alix Furgang as our new Customer Service Manager. Alix came to ulrich medical USA from Astura Medical where she managed the Customer Service team for two years. She is experienced in leading a committed team that delivers on-time set orders, sales orders, and is adept in process improvement and problem resolution. Alix earned her BS in Biochemistry from Texas Woman’s University, where she was a Research Assistant, conducted enzyme research and interned with Boston Scientific. She lives in the Dallas-Fort Worth Metroplex and is a competitive mountain biker. We welcome Alix to the ulrich team and look forward to the opportunity to work together to take your business to New Heights and BEYOND.


Melissa Pilley

We are pleased to announce Melissa Pilley as the new Regional Sales Manager of the Southwest territory for ulrich medical USA. Melissa has over ten years of medical device sales experience in biologics and spine hardware. For the last three years, she has been the Lead Principal Distributor of her independent spine business. Prior to this, Melissa earned several sales awards in her seven-year tenure at XTANT Medical, and has experience in sales at Arthrex. She also was leader of spine implant education in collaboration with the Chief of Residency at the Banner Orthopedic Residency Program.

Melissa holds a BS in Mass Communications and Public Relations from St. Johns University in New York City, where she played Division I softball. She is based in Phoenix, AZ, and is passionate about helping our distributor partners grow their business.

We welcome Melissa to the ulrich team and look forward to the opportunity to work together to take your business to New Heights and BEYOND.

ulrich Medical USA™ Receives 510(k) Clearance for Flux-C™ 3D Printed Porous Titanium Cervical Interbody Prior to NASS

ST. LOUIS, MO (October 13, 2022) — ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today announced the FDA has given 510(k) clearance of its Flux-C 3D printed porous titanium cervical interbody device.

“Surgeons have many options for cervical interbodies. The Flux-C porous titanium device offers one of the best in class with superior endplate contact and spaces for generous inter-device bone grafting. It is a welcomed complement to their superior array of expandable cages,” said Patrick Maloney, M.D. newest member of ulrich Medical USA’s Surgeon Advisory Board and its recently established Director of Deformity.

Flux-C is manufactured using a 3D printing process called direct metal laser sintering (DMLS). The interbodies are available in multiple parallel and lordotic options in various heights. These porous titanium devices are designed with a large graft window and a side window to allow for improved radiographic imaging.

Eric Lucas, Ph.D., ulrich Medical USA’s Director of Technology states, “We are continuing to develop procedural solutions for reconstruction of all spinal pathologies in collaboration with our Surgeon Advisory Board. We strive to help our surgeons and distributors achieve New Heights and Beyond with integrity, through excellence in design, manufacturing and craftsmanship.”

ulrich medical USA® Announces Corporate Relocation to Dallas-Fort Worth Metroplex

ulrich medical USA® Announces Corporate Relocation to Dallas-Fort Worth Metroplex

 

ST. LOUIS, MO (September 16, 2022)– ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today announced it will relocate its US headquarters to Plano, Texas. Its current location is in Chesterfield, Missouri.

“We believe it’s in the best strategic interest of the company to make this move, which supports ulrich medical USA’s strategy for profitable growth as we help our customers and distributors achieve new heights and beyond,” said President and CEO, Hans Stover.

The combination of the recent Sales Agency Agreement with a premier global orthopedic leader and continued organic growth are driving the need for a larger facility. Therefore, the decision was made to expand in a more business-friendly environment like that of Texas. The Dallas-Fort Worth Metroplex was an easy choice, as it has an abundance of well-educated, talented people and attractive communities which should support ulrich medical USA’s growth objectives for years to come. The company will begin transitioning its headquarters to Plano in the first quarter of 2023.

 

About ulrich Medical USA

ulrich medical USA is privately held, celebrating its 110th year as a family-owned company. Recognized as a leader in vertebral body replacement, ulrich is dedicated to remaining independent and continuing to develop a complete spine solutions portfolio that results in superior patient outcomes for years to come. ulrich medical’s global headquarters is in Ulm, Germany.

 

© ulrich medical USA. All rights reserved.

 

20220921

ulrich medical USA® Announces Exceptional First Quarter Sales

Resilient Rebound From COVID Impacts

ST. LOUIS, MO (May 21, 2021) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, reported that the first quarter of 2021 marked the strongest quarterly revenue in the company’s history.

Despite the challenges presented by COVID, monthly sales have set a new bar for ulrich medical USA. In addition, robust progress continues on the development of multiple new products that are poised to uphold the company’s century-long tradition of innovation and efficacy.

“We are grateful to our customers for allowing us to continue serving their needs,” said Pete Richardson, Vice President, Finance and Administration, ulrich medical USA. “We are also extremely proud of our team – our sales agents and managers in the field, and our in-house personnel. They have all pitched in and worked creatively to keep the gears turning, in the face of all the obstacles presented by COVID, and results like these show that our combined efforts truly matter to our customers.”

ulrich medical USA® Brings Strong Momentum® to U.S. Product Launch

Announces Nationwide Rollout of Innovative Rod-Screw System

ST. LOUIS, MO (July 13, 2020) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States announced the nationwide commercial release of the Momentum Posterior Spinal Fixation System.

“After completing hundreds of procedures during the alpha launch, Momentum has already made its mark with an enthusiastic reception and positive reviews from our alpha surgeon users,” said Erika Strecker-Laskey, Chief Commercial Officer, ulrich medical USA. “Even amid the healthcare challenges presented by the Covid-19 crisis, we have seen steadily-increasing use of Momentum during this time and a growing demand for more sets.”

Dr. Christopher F. Wagener of Allentown, PA performed multiple procedures with Momentum during the alpha launch period and said, “Momentum gives surgeons exactly what they need, both simplicity and reliability.”

Developed in St. Louis, Missouri, the new Momentum rod-screw system includes polyaxial, reduction, and iliac screws, and is compatible with ulrich medical USA’s neon3® Universal OCT Spinal Stabilization System via transition rods and connectors. This offering allows for surgical constructs capable of bridging from the sacroiliac to the cervical spine. All screws for the Momentum System are offered in a range of lengths, diameters, and angulations to accommodate unique patient anatomy. Screws are available from Ø 4.5mm to Ø 10.0mm, and in lengths from 25mm to 110mm. The system also offers both titanium and cobalt chrome rods (curved and straight) in Ø 5.5mm and Ø 6.0mm diameters. Single-use drills and taps guarantee consistent instrument performance for optimized clinical results. In addition, specialty surgical instrument modules are available for iliac fixation and deformity (basic) applications.

ulrich medical USA® Gains Momentum® in the U.S. Spine Implant Market

Demonstrates Continued Innovation with Market Entry of New Flagship Rod-Screw System

ST. LOUIS, MO (December 6, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced today the commercial release of its inaugural rod-screw system which was developed in St. Louis, Missouri. The Momentum Posterior Spinal Fixation System is the newest addition to ulrich medical USA’s growing portfolio of industry-leading spine surgery solutions.

Read more

ulrich medical USA®Announces Landmark Achievement 100,000 VBR Implant Milestone

Solidifies Spine Market Leadership Position in Vertebral Body Replacement Devices   

ST. LOUIS, MO (June 12, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, announced today that the company enterprise will surpass the 100,000 implant milestone in 2019 in total vertebral body replacement (VBR) device implantations.

Read more

ulrich medical USA®Announces Strong Continued Growth of U.S. Spine Business

Delivers 13 Consecutive Years of Organic Growth and Double Digit Positive EDITDA

ST. LOUIS, MO (April 16, 2019) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2018 financial results which continue the company’s achievement of significant year-over-year organic growth for thirteen consecutive years (since 2006).

Read more

ulrich medical USA® Delivers Seventh Consecutive Year of Profitable Double-Digit Growth

Reports 15%, 5-Year Revenue CAGR Performance in U.S. Spine Market

ST. LOUIS, MO (March 7, 2018) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2017 financial results with 10% annual revenue growth for the year ending December 31, 2017 and a 15%, 5-year compound annual growth rate (CAGR) in their U.S. spine market business.

Read more